[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Crosbie, E.J., Kitson, S.J., Mcalpine, J.N., et al. (2022) Endometrial Cancer. Lancet, 399, 1412-1428. https://doi.org/10.1016/S0140-6736(22)00323-3
|
[3]
|
Tung, H.J., Huang, H.J. and Lai, C.H. (2022) Adjuvant and Post-Surgical Treatment in Endometrial Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 78, 52-63. https://doi.org/10.1016/j.bpobgyn.2021.06.002
|
[4]
|
Hahn, H., Lee, I., Kim, T., et al. (2013) Lymphovascular Space Invasion Is Highly Associated with Lymph Node Metastasis and Recurrence in Endometrial Cancer. Australian and New Zealand Journal of Obstetrics and Gynaecology, 53, 293-297. https://doi.org/10.1111/ajo.12089
|
[5]
|
Solmaz, U., Mat, E., Dereli, M., et al. (2015) Lymphovascular Space Invasion and Cervical Stromal Invasion Are Independent Risk Factors for Nodal Metastasis in Endometrioid Endometrial Cancer. Australian & New Zealand Journal of Obstetrics & Gynaecology, 55, 81-86. https://doi.org/10.1111/ajo.12321
|
[6]
|
Rossi, E.C., Kowalski, L.D., Scalici, J., et al. (2017) A Comparison of Sentinel Lymph Node Biopsy to Lymphadenectomy for Endometrial Cancer Staging (FIRES Trial): A Multicentre, Prospective, Cohort Study. Lancet Oncology, 18, 384-392. https://doi.org/10.1016/S1470-2045(17)30068-2
|
[7]
|
Guntupalli, S.R., Zighelboim, I., Kizer, N.T., et al. (2012) Lymphovascular Space Invasion Is an Independent Risk Factor for Nodal Disease and Poor Outcomes in Endometrioid Endometrial Cancer. Gynecologic Oncology, 124, 31-35. https://doi.org/10.1016/j.ygyno.2011.09.017
|
[8]
|
Wright, J.D., Huang, Y., Burke, W.M., et al. (2016) Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer. Obstetrics and Gynecology, 127, 109-118. https://doi.org/10.1097/AOG.0000000000001194
|
[9]
|
Kilgore, L.C., Partridge, E.E., Alvarez, R.D., et al. (1995) Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling. Gynecologic Oncology, 56, 29-33. https://doi.org/10.1006/gyno.1995.1005
|
[10]
|
Cragun, J.M., Havrilesky, L.J., Calingaert, B., et al. (2005) Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer. Journal of Clinical Oncology, 23, 3668-3675. https://doi.org/10.1200/JCO.2005.04.144
|
[11]
|
Creasman, W.T., Morrow, C.P., Bundy, B.N., et al. (1987) Surgical Pathologic Spread Patterns of Endometrial Cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-2041. https://doi.org/10.1002/1097-0142(19901015)60:8 <2035::AID-CNCR2820601515>3.0.CO;2-8
|
[12]
|
Siegenthaler, F., Epstein, E., Büchi, C.A., et al. (2023) Prognostic Value of Lymphovascular Space Invasion According to the Molecular Subgroups in Endometrial Cancer. International Journal of Gynecologic Cancer, 33, 1702-1707. https://doi.org/10.1136/ijgc-2023-004606
|
[13]
|
Benedetti, P.P., Basile, S., Maneschi, F., et al. (2008) Systematic Pelvic Lymphadenectomy vs. No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial. JNCI: Journal of the National Cancer Institute, 100, 1707-1716. https://doi.org/10.1093/jnci/djn397
|
[14]
|
Kitchener, H., Swart, A.M., Qian, Q., et al. (2009) Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomised Study. Lancet, 373, 125-136. https://doi.org/10.1016/S0140-6736(08)61766-3
|
[15]
|
Colombo, N., Creutzberg, C., Amant, F., et al. (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-Up. Annals of Oncology, 27, 16-41. https://doi.org/10.1093/annonc/mdv484
|
[16]
|
Oliver-Perez, M.R., Magrina, J., Villalain-Gonzalez, C., et al. (2021) Lymphovascular Space Invasion in Endometrial Carcinoma: Tumor Size and Location Matter. Surgical Oncology, 37, Article ID: 101541. https://doi.org/10.1016/j.suronc.2021.101541
|
[17]
|
Meydanli, M.M., Aslan, K., Oz, M., et al. (2020) Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer? International Journal of Gynecological Pathology, 39, 213-220. https://doi.org/10.1097/PGP.0000000000000596
|
[18]
|
Kim, S.I., Yoon, J.H., Lee, S.J., et al. (2021) Prediction of Lymphovascular Space Invasion in Patients with Endometrial Cancer. International Journal of Medical Sciences, 18, 2828-2834. https://doi.org/10.7150/ijms.60718
|
[19]
|
Zhou, X., Wang, H. and Wang, X. (2017) Preoperative CA125 and Fibrinogen in Patients with Endometrial Cancer: A Risk Model for Predicting Lymphovascular Space Invasion. Journal of Gynecologic Oncology, 28, e11. https://doi.org/10.3802/jgo.2017.28.e11
|
[20]
|
Laufer, J., Scasso, S., Papadia, A., et al. (2013) Association between Tumor Diameter and Lymphovascular Space Invasion among Women with Early-Stage Endometrial Cancer. International Journal of Gynecology & Obstetrics, 123, 142-145. https://doi.org/10.1016/j.ijgo.2013.05.012
|
[21]
|
Nougaret, S., Horta, M., Sala, E., et al. (2019) Endometrial Cancer MRI Staging: Updated Guidelines of the European Society of Urogenital Radiology. European Radiology, 29, 792-805. https://doi.org/10.1007/s00330-018-5515-y
|
[22]
|
Ytre-Hauge, S., Husby, J.A., Magnussen, I.J., et al. (2015) Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas. International Journal of Gynecological Cancer, 25, 459-466. https://doi.org/10.1097/IGC.0000000000000367
|
[23]
|
Bourgioti, C., Chatoupis, K., Tzavara, C., et al. (2016) Predictive Ability of Maximal Tumor Diameter on MRI for High-Risk Endometrial Cancer. Abdominal Radiology, 41, 2484-2495. https://doi.org/10.1007/s00261-016-0927-0
|
[24]
|
Chen, J., Wang, X., Lv, H., et al. (2023) Development and External Validation of a Clinical-Radiomics Nomogram for Preoperative Prediction of LVSI Status in Patients with Endometrial Carcinoma. Journal of Cancer Research and Clinical Oncology, 149, 13943-13953. https://doi.org/10.1007/s00432-023-05044-y
|
[25]
|
Raffone, A., Travaglino, A., Raimondo, D., et al. (2022) Lymphovascular Space Invasion in Endometrial Carcinoma: A Prognostic Factor Independent from Molecular Signature. Gynecologic Oncology, 165, 192-197. https://doi.org/10.1016/j.ygyno.2022.01.013
|
[26]
|
Peters, E.E.M., Léon-Castillo, A., Hogdall, E., et al. (2022) Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer. International Journal of Gynecological Pathology, 41, 227-234. https://doi.org/10.1097/PGP.0000000000000805
|
[27]
|
Tortorella, L., Restaino, S., Zannoni, G.F., et al. (2021) Substantial Lymph-Vascular Space Invasion (LVSI) as Predictor of Distant Relapse and Poor Prognosis in Low-Risk Early-Stage Endometrial Cancer. Journal of Gynecologic Oncology, 32, e11. https://doi.org/10.3802/jgo.2021.32.e11
|
[28]
|
Stålberg, K., Bjurberg, M., Borgfeldt, C., et al. (2019) Lymphovascular Space Invasion as a Predictive Factor for Lymph Node Metastases and Survival in Endometrioid Endometrial Cancer—A Swedish Gynecologic Cancer Group (SweGCG) Study. Acta Oncologica, 58, 1628-1633. https://doi.org/10.1080/0284186X.2019.1643036
|
[29]
|
Restaino, S., Tortorella, L., Dinoi, G., et al. (2021) Semiquantitative Evaluation of Lymph-Vascular Space Invasion in Patients Affected by Endometrial Cancer: Prognostic and Clinical Implications. European Journal of Cancer, 142, 29-37. https://doi.org/10.1016/j.ejca.2020.10.011
|
[30]
|
Jorge, S., Hou, J.Y., Tergas, A.I., et al. (2016) Magnitude of Risk for Nodal Metastasis Associated with Lymphvascular Space Invasion for Endometrial Cancer. Gynecologic Oncology, 140, 387-393. https://doi.org/10.1016/j.ygyno.2016.01.002
|
[31]
|
Sari, M.E., Yalcin, I., Sahin, H., et al. (2017) Risk Factors for Paraaortic Lymph Node Metastasis in Endometrial Cancer. International Journal of Clinical Oncology, 22, 937-944. https://doi.org/10.1007/s10147-017-1139-5
|
[32]
|
O’Brien, D.J., Flannelly, G., Mooney, E.E. and Foley, M. (2009) Lymphovascular Space Involvement in Early Stage Well-Differentiated Endometrial Cancer Is Associated with Increased Mortality. BJOG: An International Journal of Obstetrics & Gynaecology, 116, 991-994. https://doi.org/10.1111/j.1471-0528.2009.02162.x
|
[33]
|
Pollom, E.L., Conklin, C.M., Von Eyben, R., et al. (2016) Nomogram to Predict Risk of Lymph Node Metastases in Patients with Endometrioid Endometrial Cancer. International Journal of Gynecological Pathology, 35, 395-401. https://doi.org/10.1097/PGP.0000000000000246
|
[34]
|
Folkins, A.K., Nevadunsky, N.S., Saleemuddin, A., et al. (2010) Evaluation of Vascular Space Involvement in Endometrial Adenocarcinomas: Laparoscopic vs Abdominal Hysterectomies. Modern Pathology, 23, 1073-1079. https://doi.org/10.1038/modpathol.2010.91
|
[35]
|
Kumar, S., Bandyopadhyay, S., Semaan, A., et al. (2011) The Role of Frozen Section in Surgical Staging of Low Risk Endometrial Cancer. PLOS ONE, 6, e21912. https://doi.org/10.1371/journal.pone.0021912
|
[36]
|
Karabagli, P., Ugras, S., Yilmaz, B.S. and Celik, C. (2015) The Evaluation of Reliability and Contribution of Frozen Section Pathology to Staging Endometrioid Adenocarcinomas. Archives of Gynecology and Obstetrics, 292, 391-397. https://doi.org/10.1007/s00404-015-3621-5
|
[37]
|
Chen, J., Li, L., Chen, T., et al. (2022) Predicting the Risk of Active Pulmonary Tuberculosis in People Living with HIV: Development and Validation of a Nomogram. BMC Infectious Diseases, 22, Article No. 388. https://doi.org/10.1186/s12879-022-07368-5
|